TITLE

Genetronics Biomedical Corp

PUB. DATE
October 2002
SOURCE
San Diego Business Journal;10/7/2002, Vol. 23 Issue 40, p31
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Features San Diego, California-based biotechnology firm Genetronics Biomedical Corp. Company background; Market valuation; Financial performance; Corporate directors; Executive salaries; Contact information.
ACCESSION #
7527896

 

Related Articles

  • GENETRONICS/GENTERIC TO DELIVER DNA TO SALIVARY GLAND.  // Biotech Business;Jul2003, Vol. 16 Issue 7, p6 

    Deals with the research agreement between Genetronics Biomedical Corp. and Genteric Inc. to evaluate gene expression using electroporation-assisted delivery of DNA to the salivary gland.

  • Genetronics Biomedical Ltd.  // San Diego Business Journal;11/09/98, Vol. 19 Issue 45, p47 

    Presents information about San Diego, California-based Genetronics Biomedical Ltd., taken from proxy statement filed as of November 9, 1998. Value; Performance record; Directors; Executive compensation; Significant stock ownership; Other information.

  • HARVARD BIOSCIENCE ACQUIRES BTX DIVISION OF GENETRONICS.  // Biotech Financial Reports;Feb2003, p6 

    Reports that Harvard Bioscience Inc. has signed a definitive agreement with Genetronics Biomedical Corporation to purchase the non-cash assets of its BTX Division. Terms of the sale; Details regarding BTX Division; Profile of Harvard Bioscience Inc.; Website information to know about Harvard...

  • Tumor Ablator Trials Travel Drug Path, But Sponsor Seeks Device Regulation.  // Medical Design Technology;Apr2005, Vol. 9 Issue 4, p8 

    Reports on the plan of Genetronics Biomedical Corp. to pursue clinical development of the MedPulsar tumor ablation system through a device regulatory route in the U.S. Intention of the company to complete enrollment for phase I drug trials of MedPulsar in combination of the anti-tumor drug...

  • Impotency therapy developed.  // San Diego Business Journal;07/13/98, Vol. 19 Issue 28, p9 

    Reports on Genetronics Biomedical Ltd.'s completion of animal efficacy and human tolerance testing for its proprietary transdermal drug delivery (TDD) method to deliver a vasodilating drug. Development of a needleless TDD device which uses electroincorporation.

  • Idec's Quarterly Earnings Show Solid Growth. Webb, Marion // San Diego Business Journal;7/28/2003, Vol. 24 Issue 30, p9 

    Reports developments on issues related to the business industry in San Diego, California as of August 2003. Financial performance of Idec Pharmaceutical Corp.; Amount of money raised by Genetronics Biomedical Corp. through two separate preferred stock offerings to institutional and accredited...

  • Genetronics technology used in recent clonings. Webb, Marion // San Diego Business Journal;03/02/98, Vol. 19 Issue 9, p11 

    Presents news briefs on biotechnology. Use of Genetronics Biomedical Ltd.'s gene therapy process of electroporation in two reported cloning experiments; Process of electroporation; Maxim Pharmaceuticals, Inc.'s phase III clinical trials for Maxamine Therapy; Patent approval received by Acadia...

  • Electrodes spark death of skin cancers. Coghlan, Andy // New Scientist;10/7/95, Vol. 148 Issue 1998, p24 

    Cites the claim of San Diego, California-based Genetronics that skin cancers have been eradicated in some patients by a system that uses electrical pulses to pump anticancer drugs into the tumors. Injection of an anticancer drug around the tumor; Success of a clinical trial in Tampa, Florida.

  • Genetronics strikes a deal.  // San Diego Business Journal;11/22/99, Vol. 20 Issue 47, p5 

    Announces Genetronics Biomedical Ltd.'s signing of a gene-therapy deal with German pharmaceutical giant Boehringer Ingelheim.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics